Molecular Cytogenetics Market Size, Share, By Products (Instruments, Kits & Reagents, and Software & Services), By Technology (FISH, Comparative Genomic Hybridization, Immunohistochemistry, Karyotyping, and Others), By Application (Genetic Disorders, and Oncology), By End- Use (Clinical & Research Laboratories, Hospitals & Path Labs, and Pharmaceutical & Biotech Companies), and By Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America) - Trends, Analysis and Forecast till 2034

Report Code: PMI527724 | Publish Date: June 2024 | No. of Pages: 187

Molecular Cytogenetics Market Companies

  • Danaher
  • MetaSystems
  • Agilent Technologies, Inc.
  • Abbott
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Oxford Gene Technology
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • GeneDx
  • CytoTest Inc.
  • Empire Genomics
  • PerkinElmer Inc.

Recent News:

  • In June 2023, Oxford Gene Technology (OTG) and Applied Spectral Imaging (ASI) partnered to enhance OTG's cytogenetic imaging and analysis offerings in the United Kingdom. The programme is anticipated to provide improvements in workflow automation and overall efficacy to facilitate faster diagnostic decision-making.
  • In March 2022, Illumina, Inc. introduced TruSight Oncology (TSO) Comprehensive (EU). This single assessment evaluates several tumour genes and biomarkers to identify a patient's cancer's precise molecular profile. The in vitro diagnostic (IVD) kit will assist in informing precision medicine decisions for cancer patients throughout the region, with its global debut initially occurring in Europe.